Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated 3 min ago
Peer-reviewedLicence not statedThe Journal of clinical psychiatry

GLP-1 Receptor Agonists and Risk of Kidney Replacement Therapy and Healthcare Utilization in Bipolar Disorder with Chronic Kidney Disease

  1. 1Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA
  2. 2Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA
  3. 3Penn State College of Medicine, Hershey, PA, USA

Related

  1. Potential for GLP-1 Receptor Agonists in Irritable Bowel Syndrome
    Michael Camilleri, Alexander C. Ford
    GastroenterologyPeer-reviewedLicence not statedFull textGeneral medicinePMC
  2. Glucagon-like peptide-1 receptor agonists beyond weight loss: A paradigm shift in cardiovascular prevention
    Alaa Solaiman Algazzar
    Saudi Journal of Internal MedicinePeer-reviewedCC BY-NC-NDFull textEndocrinology & metabolismDOAJ
  3. Divergent ocular safety profiles of glucagon-like peptide-1 receptor agonists: a pharmacological heterogeneity framework
    Huili Li, Shengke Peng, Daoxi Lei
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. GLP-1 Receptor Agonists Added to Statin Therapy and Cardiovascular Outcomes in ASCVD A Propensity Score-Matched Cohort Study
    S. Tah, M. Cheshire
    medRxivPreprintAll rights reservedFull textCardiovascular medicinemedRxiv
  5. Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review
    Audrey Y. Chang, Farrah J. Mateen
    Annals of clinical and translational neurologyPeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{singh2026glp1,
  title = {{GLP-1 Receptor Agonists and Risk of Kidney Replacement Therapy and Healthcare Utilization in Bipolar Disorder with Chronic Kidney Disease}},
  author = {Balwinder Singh and Maria L Gonzalez Suarez and Hossam M Ali and Raman Baweja},
  journal = {The Journal of clinical psychiatry},
  year = {2026},
  month = oct,
  doi = {10.4088/jcp.26m16392},
  url = {https://doi.org/10.4088/jcp.26m16392},
}
RIS
TY  - JOUR
TI  - GLP-1 Receptor Agonists and Risk of Kidney Replacement Therapy and Healthcare Utilization in Bipolar Disorder with Chronic Kidney Disease
AU  - Balwinder Singh
AU  - Maria L Gonzalez Suarez
AU  - Hossam M Ali
AU  - Raman Baweja
PY  - 2026
DA  - 2026/10/05
JO  - The Journal of clinical psychiatry
DO  - 10.4088/jcp.26m16392
UR  - https://doi.org/10.4088/jcp.26m16392
SN  - 0160-6689
SN  - 1555-2101
ER  -